SCHEMBL14655287

SCHEMBL14655287

NC(=O)[CH]CC(=O)NC1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LMNA P02545 2/20 0.39
▸ KMT2A Q03164 4/20 0.38
▸ HPGD P15428 4/20 0.38
▸ EPHX1 P07099 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ EPHX2 P34913 1/20 0.35
▸ HDAC3 O15379 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ HDAC10 Q969S8 2/20 0.35
▸ HDAC11 Q96DB2 2/20 0.35
▸ HDAC8 Q9BY41 2/20 0.35
▸ HDAC6 Q9UBN7 2/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ SMYD3 Q9H7B4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322890 0.92 SMN1; SMN2 (0.47) SMN1; SMN2LMNAKMT2AHPGDEPHX1
SCHEMBL15055532 0.76 — —
SCHEMBL13690844 0.73 KMT2A (0.47) SMN1; SMN2LMNAKMT2AHPGDEPHX1
SCHEMBL3135300 0.70 — —
SCHEMBL16853215 0.70 SMN1; SMN2 (0.48) SMN1; SMN2LMNAKMT2AHPGDEPHX1
SCHEMBL5015412 0.69 CNR2 (0.50) SMN1; SMN2LMNAKMT2AHPGDEPHX1
SCHEMBL5017491 0.69 CNR2 (0.50) SMN1; SMN2LMNAKMT2AHPGDEPHX1
SCHEMBL10132085 0.69 SMN1; SMN2 (0.65) SMN1; SMN2LMNAKMT2AHPGDEPHX1
Hydrochloric Acid SCHEMBL1996186 0.69 — —
SCHEMBL12457773 0.68 EPHX1 (0.53) SMN1; SMN2LMNAKMT2AHPGDEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481541-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-07-09 — — US claimed
EP-2550274-A1 PYRROLOPYRAZINE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 — — EP claimed
US-8481541-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-07-09 — — US disclosed
EP-2550274-A1 PYRROLOPYRAZINE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 — — EP disclosed
Send feedback